These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15675498

  • 1. Antiretroviral drug therapy in HIV-infected Jamaican children.
    Evans-Gilbert T, Pierre R, Steel-Duncan JC, Rodriguez B, Whorms S, Hambleton IR, Figueroa JP, Christie CD.
    West Indian Med J; 2004 Oct; 53(5):322-6. PubMed ID: 15675498
    [Abstract] [Full Text] [Related]

  • 2. CDC-defined diseases and opportunistic infections in Jamaican children with HIV/AIDS.
    Pierre R, Steel-Duncan JC, Evans-Gilbert T, Rodriguez B, Palmer P, Smikle MF, Whorms S, Hambleton I, Figueroa JP, Christie CD.
    West Indian Med J; 2004 Oct; 53(5):315-21. PubMed ID: 15675497
    [Abstract] [Full Text] [Related]

  • 3. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS, Boland MG, Gortmaker SL, He Y, Skurnick J, Howland L, Oleske JM, Pediatric AIDS Clinical Trials Group Protocol 219 Study Team.
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [Abstract] [Full Text] [Related]

  • 4. Impact on weight and height with the use of HAART in HIV-infected children.
    Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA.
    Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
    [Abstract] [Full Text] [Related]

  • 5. Tuberculosis and HIV co-infections in Jamaican children.
    Geoghagen M, Farr JA, Hambleton I, Pierre R, Christie CD.
    West Indian Med J; 2004 Oct; 53(5):339-45. PubMed ID: 15675501
    [Abstract] [Full Text] [Related]

  • 6. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
    Funk MB, Buchholz B, Notheis G, Neubert J, Feiterna-Sperling C, Ganschow R, Simon T, Hornemann F, Peters AM, Rütschle H, Horneff G, Lechner E, Hanschmann KM, Wintergerst U, Paediatric Working Group AIDS (PAAD).
    Eur J Med Res; 2008 Aug 18; 13(8):371-8. PubMed ID: 18952519
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy.
    Miziara ID, Weber R, Araújo Filho BC, Pinheiro Neto CD.
    J Laryngol Otol; 2007 Nov 18; 121(11):1048-54. PubMed ID: 17319998
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of antiretroviral therapy in human immunodeficiency virus-infected children.
    Chearskul P, Chokephaibulkit K, Chearskul S, Phongsamart W, Plipat N, Lapphra K, Vanprapar N.
    J Med Assoc Thai; 2005 Nov 18; 88 Suppl 8():S221-31. PubMed ID: 16856444
    [Abstract] [Full Text] [Related]

  • 13. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
    Chiappini E, Galli L, Tovo PA, Gabiano C, Gattinara GC, Guarino A, Badolato R, Giaquinto C, Lisi C, de Martino M, Italian Register for HIV Infection in Children.
    AIDS; 2006 Jan 09; 20(2):207-15. PubMed ID: 16511413
    [Abstract] [Full Text] [Related]

  • 14. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
    Newell ML, Patel D, Goetghebuer T, Thorne C, European Collaborative Study.
    J Infect Dis; 2006 Apr 01; 193(7):954-62. PubMed ID: 16518757
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team.
    Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042
    [Abstract] [Full Text] [Related]

  • 18. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.
    Pediatrics; 2005 Apr 15; 115(4):e488-94. PubMed ID: 15772172
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.